Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2024-06-11 00:00:00 ET · period of report 2024-06-07 · accession 0001579587-24-000013 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-06-11 | 2024-06-07 | ANIP | Marken James G. | SVP OPS, PROD DEV | M - OptEx | $52.70 | +12.6K | 123.6K | +11% | +$661.4K |
| D | 2024-06-11 | 2024-06-07 | ANIP | Marken James G. | SVP OPS, PROD DEV | F - Tax | $67.70 | -11.1K | 117.8K | -9% | -$750.6K |
| DM | 2024-06-11 | 2024-06-07 | ANIP | Marken James G. | SVP OPS, PROD DEV | M - OptEx | $52.70 | -12.6K | 0 | -100% | -$661.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-07 | M | A | 5,300 | $57.06 | 128,916 | D | — | — | |
| 2 | Common | Common Stock | 2024-06-07 | M | A | 7,250 | $49.51 | 123,616 | D | — | — | (F1) The number of shares beneficially owned by the reporting person is amended in this Form 4 to correct an administrative error in a Form 4 filed on March 9, 2023, which misreported that 1,951 shares were withheld on March 7, 2023 to cover taxes on a vesting of shares on that date, when 1,591 shares were withheld. In correcting this administrative error, the number of shares beneficially owned by the reporting person reflects an increase of 360 shares. |
| 3 | Common | Common Stock | 2024-06-07 | F | D | 11,087 | $67.70 | 117,829 | D | — | — | (F2) The shares were sold in multiple trades at prices ranging from $67.64 to $68.10. The price reported above reflects the weighted average sales price. |
| 4 | Derivative | Stock Option (right to buy) | 2024-06-07 | M | D | 5,300 | $57.06 | 0 | D | $57.06 · — to 2028-04-05 | 5,300 Common Stock | (F4) 25% of the total options vested on each of April 6, 2019, April 6, 2020, April 6, 2021, and April 6, 2022. |
| 5 | Derivative | Stock Option (right to buy) | 2024-06-07 | M | D | 7,250 | $49.51 | 0 | D | $49.51 · — to 2027-03-30 | 7,250 Common Stock | (F3) 25% of the total options vested on each of March 31, 2018, March 31, 2019, March 31, 2020, and March 31, 2021. |